A PK, Safety and Tolerability Study of Peripheral and Central Infusion of Melflufen in RRMM Patients
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to RRMM
Related studies linked through entity extraction aliases.
Integrin β7, BCMA, CS1, CD38 and CD138 as the Single or Compound Targets for the Fourth Genenation of CAR-T Cells
- Status
- UNKNOWN
- Phase
- PHASE1
Study of Pembrolizumab (MK-3475) in Combination With Dinaciclib (MK-7965) in Hematologic Malignancies (MK-3475-155/KEYNOTE-155)
- Status
- TERMINATED
- Phase
- PHASE1